Renesas beat revenue but missed earnings; the real signal is a margin reset hidden by demand recovery

The setup into this print was not demanding on revenue, but it was still too optimistic on earnings quality. What was priced in, on the street-comparison basis, was revenue of ¥2,194.8 million and EPS of ¥0.14. What actually surprised was bifurcated: revenue came in at ¥2,241.6 million, a +2.1% surprise, while EPS was ¥0.03, a -78.4% surprise. That combination matters because the top-line beat did not carry through the income statement, and the historical quarterly record shows why the market should be careful about paying for the recovery too early. Q4 FY2025 revenue in the company history was ¥415,588.5 million, up +23.9% QoQ and +42.0% YoY, but gross margin fell to 35.6% and diluted EPS was only ¥4.88. A revenue acceleration of +23.9% QoQ normally should be the cleanest part of the semiconductor cycle for operating leverage; instead, Renesas printed the weakest gross margin in the provided history at 35.6%, below Q1 FY2024’s 47.8% and far below the 55.3% to 57.9% range that characterized the eight quarters from Q1 FY2023 through Q2 FY2025 except for Q1 FY2024. The market may be missing that the surprise is not the return of demand, it is the failure of Q4 demand to protect margin.

That margin failure is the anchor for the thesis because Q1 FY2026 partially repairs the damage, but does not erase it. The next quarter in the history shows revenue of ¥387,279.4 million, down -6.8% QoQ but up +25.4% YoY, with gross margin back to 51.2% and diluted EPS at ¥19.18. The improvement from Q4 FY2025’s 35.6% gross margin to Q1 FY2026’s 51.2% is large, but the endpoint still sits below Q3 FY2025’s 49.2% only by comparison? No, the endpoint is above Q3 FY2025’s 49.2%, yet still below Q1 FY2025’s 56.0%, Q2 FY2025’s 55.7%, Q4 FY2024’s 55.3%, Q3 FY2024’s 55.7%, Q2 FY2024’s 56.0%, Q4 FY2023’s 56.2%, Q3 FY2023’s 57.9%, and Q2 FY2023’s 57.3%. The market can underwrite recovery if 51.2% is a bridge, but not if it is the new ceiling after capacity expansion and Diebank build. That distinction is why the EPS miss is more investable than the revenue beat: it points to the variable that will decide the stock, not the variable that merely confirms the cycle has stopped getting worse.

The company’s own language points to a demand recovery, but it also shows management is leaning into inventory and capacity before the margin proof is complete. Shuhei Shinkai said, “For Q1, we are expecting an increase in amount Q-on-Q due to demand recovery, we will be expanding the Diebank in anticipation.” The wording matters because “in anticipation” is not the same as demand already booked through sell-through; it is a working-capital and utilization bet made after a quarter in which gross margin was 35.6%. The same call also carried a Q1 midpoint framework of “revenue and the midpoint forecast, it's JPY 375 billion; gross margin, 58.5%; operating profit margin, 32%; and FX, JPY 154 against the dollar and against JPY 182 against the euro,” per Shuhei Shinkai. That company-account basis should not be mixed with the street-comparison print of ¥2,241.6 million, but it is useful because it defines management’s bar: the thesis breaks if Renesas cannot move from Q4 FY2025’s 35.6% gross margin and Q1 FY2026’s 51.2% toward the stated 58.5% gross margin framework while sustaining revenue close to ¥375 billion.

The historical trajectory also shows that Renesas is not merely lapping an easy quarter; it is exiting a volatile profit period that investors may be too quick to normalize. Revenue fell -15.3% QoQ and -19.2% YoY in Q4 FY2024 to ¥292,600.0 million, then recovered sequentially in Q1 FY2025 by +5.5% to ¥308,777.0 million, in Q2 FY2025 by +5.4% to ¥325,534.0 million, in Q3 FY2025 by +3.0% to ¥335,364.0 million, and then jumped +23.9% in Q4 FY2025 to ¥415,588.5 million. But EPS quality over the same period was uneven: ¥5.25 in Q4 FY2024, ¥7.15 in Q1 FY2025, -¥55.17 in Q2 FY2025, ¥29.02 in Q3 FY2025, and ¥4.88 in Q4 FY2025. The stock’s bullish argument needs the Q4 revenue jump to be an inflection; the bear case needs only to show that the revenue jump was not enough. The reported gross margin of 35.6% in Q4 FY2025 and EPS of ¥4.88 after ¥335,364.0 million of Q3 revenue and ¥29.02 of Q3 EPS give the bear case more than enough evidence unless the Q1 FY2026 rebound to 51.2% gross margin proves sustainable.

The quarter’s customer-market message is positive but not broad enough to ignore the inventory risk. Hidetoshi Shibata said, “But beyond that, the end demand outlook, so Automotive, IIoT, we are expecting a moderate growth, specifically for IIoT.” The word “moderate” matters because it caps the interpretation: this is not a management team claiming a vertical takeoff in automotive and industrial demand. The numbers line up with a moderate recovery rather than a boom. Q1 FY2026 revenue of ¥387,279.4 million is down -6.8% QoQ from Q4 FY2025’s ¥415,588.5 million even though it is up +25.4% YoY from Q1 FY2025’s ¥308,777.0 million. If IIoT is the better part of the outlook, then suppliers tied to capacity enablement rather than only end-demand pull may see the more immediate read-through. That distinction matters for portfolio construction across the chain: Renesas is acting as if demand is recovering, but the P&L says the recovery is not yet clean.

The supply-chain read-through is therefore specific and mixed. For Organo Corporation, which supplies ultrapure water and chemical treatment systems, and Taiyo Nippon Sanso, which supplies bulk and specialty gases, the relevant Renesas data point is management’s plan to invest toward capacity expansion after Q4 FY2025 revenue of ¥415,588.5 million and Q1 FY2026 revenue of ¥387,279.4 million. For Andes Technology, which provides RISC-V CPU cores including AndesCore N25F, A25MP, and AX45MP, and CEVA, which provides Wi-Fi 6 and Bluetooth IP and DSP for ITS, the read-through is that IIoT and automotive content remains alive, but management’s “moderate growth” language does not justify assuming acceleration beyond the +25.4% YoY Q1 FY2026 revenue growth shown in Renesas’ own history. For Imagination Technologies, whose IMG B-Series GPU IP is used for R-Car Gen 5 SoC, the call adds a design-content clue: Daiki Takayama said share positioning is “about 1/3 to 50% for GPU,” while Hidetoshi Shibata said Gen 4 Alcon will “start to pick up as well.” For Wolfspeed, the 150mm/200mm SiC wafer relationship is strategically relevant, but this print does not quantify SiC pull-through; the quantified support is only Renesas’ Q1 FY2026 revenue of ¥387,279.4 million, +25.4% YoY, and its capacity-expansion language.

The peer comparison reinforces the same point: Renesas has the growth, but the margin debate is not settled. In the subsector IDM table, RNECY shows ¥387,279.4 million of revenue, 51.2% gross margin, and +25.4% revenue YoY. That YoY growth is ahead of 6758.T at +15.4%, 6724.T at +8.9%, INTC at +7.2%, TXN at +18.6%, IFNNY at +7.9%, NXPI at +12.2%, and STM at +22.8%. But Renesas’ 51.2% gross margin trails TXN’s 58.0% and NXPI’s 56.2%, while sitting above INTC’s 39.4%, IFNNY’s 38.7%, 6724.T’s 35.0%, STM’s 33.8%, and 6758.T’s 30.8%. The market may be tempted to focus on Renesas’ top position on YoY growth in that set, but the more actionable comparison is to the analog and auto-exposed margin leaders: a Renesas rerating needs evidence that 51.2% is moving toward NXPI’s 56.2% and TXN’s 58.0%, not simply that revenue growth is above peers for one quarter.

The call delivery supports a constructive near-term read, but it is not clean enough to override the accounting volatility. The tone history improved on the surface from Q4 FY2025 to Q1 FY2026: sentiment rose by +0.18 to 0.20, guidance_tone rose by +0.26 to 0.39, and qa_sentiment rose by +0.10 to 0.12. Those are meaningful changes because they came alongside Q1 FY2026 revenue of ¥387,279.4 million and gross margin of 51.2%, not just management optimism after a bad quarter. Yet tone_confidence fell by -0.09 to 0.44, ai_optimism fell by -0.10 to 0.26, uncertainty stayed elevated at 68.5, and qa_evasiveness stayed elevated at 69.5. In other words, the model reads management as more positive on guidance but not more confidently optimistic. That aligns with the numbers: Q1 recovered from Q4’s 35.6% gross margin shock, but the company is still managing demand recovery, Diebank expansion, capacity investment, and FX sensitivity at the same time.

That tonal mix also explains why the print should not be dismissed as just a noisy EPS miss. Management did give investors concrete operating levers: Shuhei Shinkai said, “For operating margin, we are expecting 1.2 points higher operating margins Q-on-Q to 32% due to volume growth due to revenue growth.” The value of that quote is the causal claim: margin expansion is tied to volume growth, not only cost cuts or mix. That is exactly where the investment debate should sit. If revenue falls -6.8% QoQ in Q1 FY2026 and still produces 51.2% gross margin and ¥19.18 EPS, the business has already shown some ability to recover after the Q4 margin trough. But if the company’s own framework requires revenue near ¥375 billion, gross margin of 58.5%, and operating profit margin of 32%, then the next validation point is not whether revenue can be up YoY; it is whether a lower sequential revenue base can carry much higher gross margin and operating margin. The Q4 FY2025 combination of ¥415,588.5 million revenue, 35.6% gross margin, and ¥4.88 EPS says volume alone is insufficient.

The FX comments add another reason to keep the thesis centered on margin, not revenue. The company’s Q1 framework used FX of JPY 154 against the dollar and JPY 182 against the euro, while the full-year account basis cited ForEx assumptions of JPY 150 to the dollar and JPY 167 to the euro. Shuhei Shinkai also gave a sensitivity statement: “Based off the sensitivity, the forecast for Q1 and OP margins of 32%, we -- at JPY 100 against the dollar and JPY 120 against the euro, OP margins will be 25.7%.” That is a wide operating-margin sensitivity attached to currency, and it makes the revenue beat less informative as a standalone signal. If the market prices Renesas on +25.4% YoY Q1 FY2026 revenue growth without discounting the FX and capacity assumptions embedded in the margin path, it is over-crediting the least scarce part of the story. The scarce part is proof that gross margin can hold above 51.2% and move toward the company’s 58.5% framework while Diebank and capacity investment rise.

The actionable conclusion is that Renesas is a recovery story with an unproven margin bridge, not an earnings-quality story that has already turned. The revenue surprise of +2.1% versus the street was real, and the sequential revenue history from ¥292,600.0 million in Q4 FY2024 to ¥415,588.5 million in Q4 FY2025 shows demand improved. But the EPS surprise of -78.4%, the Q4 FY2025 gross margin of 35.6%, and the gap between Q1 FY2026 gross margin of 51.2% and the company-account Q1 framework of 58.5% are the numbers that should drive position sizing. A PM should be willing to own the recovery only if the next quarter confirms that Q4 was a transient margin trough caused by timing, inventory, or mix rather than the first visible cost of rebuilding capacity ahead of demand.

What to watch next is concrete. By the next quarterly update after the 2026-02-04 call, the thesis is confirmed if revenue stays near the company-account midpoint of ¥375 billion, gross margin moves toward 58.5%, and operating profit margin tracks the stated 32% rather than only the historical Q1 FY2026 gross margin of 51.2%. It is also confirmed if uncertainty and qa_evasiveness in the tone series fall from 68.5 and 69.5 while guidance_tone holds near 0.39, because that would mean management is not merely more positive but more precise. The thesis breaks if revenue remains close to the Q1 FY2026 historical level of ¥387,279.4 million but gross margin fails to improve from 51.2%, or if Diebank and capacity spending language intensifies without a path back toward 58.5%. The specific red flag is another quarter where revenue is up materially YoY, as Q1 FY2026 was at +25.4%, but EPS does not follow the direction implied by ¥19.18 and operating margin does not approach 32%.